NEO
NEOGENOMICS INC
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$19.91
+0.10%Next report
Analyst consensus
- Next report date
- Oct 27, 2026
- EPS estimate
- $0.06
- Revenue estimate
- $205.9M
Latest reported
- Last report date
- Jul 28, 2026
- EPS actual
- $0.05
- EPS estimate
- $0.03
- Revenue actual
- $201.7M
- Revenue estimate
- $196.9M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 7
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 2
- Avg surprise (4Q)
- +55.5%
- Revenue beats (12Q)
- 5
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $18
- PT range
- $16 – $19
- Analysts
- 2
2 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Jul 28, 2026 | $0.03 | $0.05 | Beat 49.03% | $201.7M |
| Apr 28, 2026 | $0.01 | $0.01 | Beat 73.01% | $186.7M |
| Feb 17, 2026 | $0.04 | $0.06 | Beat 50.00% | $190.2M |
| Oct 28, 2025 | $0.02 | $0.03 | Beat 50.00% | $187.8M |
| Jul 29, 2025 | $0.03 | $0.03 | In line | $181.3M |
| Apr 29, 2025 | -$0.02 | -$0.08 | Miss -300.00% | $168.0M |
| Feb 18, 2025 | $0.03 | $0.04 | Beat 33.33% | $172.0M |
| Apr 30, 2024 | -$0.01 | -$0.02 | Miss -59.24% | $156.2M |
| Feb 20, 2024 | $0.01 | $0.03 | Beat 220.51% | $155.6M |
| Feb 23, 2023 | -$0.15 | -$0.06 | Beat 60.00% | $138.7M |
| Feb 23, 2022 | -$0.13 | -$0.14 | Miss -7.69% | $125.7M |
| Nov 4, 2021 | -$0.08 | -$0.08 | In line | $121.3M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 27, 2026